| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Ipratropium | Ipratropium EP Impurity A | VE007069 | View CAS 58005-18-8 |
| Ipratropium | Ipratropium EP Impurity B (Bromide Salt) | VE008195 | View CAS 58073-59-9 |
| Ipratropium | Ipratropium EP Impurity C | VL1940001 | View CAS 552-63-6 |
| Ipratropium | Ipratropium EP Impurity D | VL1940002 | View CAS 492-38-6 |
| Ipratropium | Ipratropium EP Impurity E | VL1940004 | View CAS 183626-76-8 |
| Ipratropium | Ipratropium EP Impurity F | VL1940003 | View CAS 17812-46-3 |
| Catalogue No. | VL1940003 |
| CAS No. | 17812-46-3 |
| Molecular Formula | C20H28BrNO2 |
| Molecular Weight | 394.35 |
| Parent drug | Ipratropium |
| IUPAC Name | (1R, 3r, 5S, 8r)-8-Methyl-8-(1-methylethyl)-3-[(2-phenylpropenoyl)oxy]-8-azoniabicyclo[3.2.1]octane bromide ; |
| Synonyms | apo-Ipratropium Bromide |
| References | Sci-Hub, Simultaneous determination of ipratropium and salbutamol in rat plasma by LC–MS/MS and its application to a pharmacokinetic study, 10.1016/j.jchromb.2011.09.027. (2022). Hkvisa.net. https://sci-hub.hkvisa.net/10.1016/j.jchromb.2011.09.027 |
| Status | In-stock |
| ListName | Ipratropium EP Impurity F |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
